TargetCaspase-3(Homo sapiens (Human))
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
Affinity DataIC50: 8.90E+5nMpH: 5.8Assay Description:Assay buffers consist of 20 mM citric acid, 60 mM disodium hydrogen orthophosphate, 1 mM EDTA, 0.1% CHAPS, 4 mM DTT, pH 5.8 for legumain, 50 mM dihyd...More data for this Ligand-Target Pair
TargetCaspase-3(Homo sapiens (Human))
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
Affinity DataIC50: 130nMpH: 5.8Assay Description:Assay buffers consist of 20 mM citric acid, 60 mM disodium hydrogen orthophosphate, 1 mM EDTA, 0.1% CHAPS, 4 mM DTT, pH 5.8 for legumain, 50 mM dihyd...More data for this Ligand-Target Pair
TargetCaspase-3(Homo sapiens (Human))
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
Affinity DataIC50: 2.80E+3nMpH: 5.8Assay Description:Assay buffers consist of 20 mM citric acid, 60 mM disodium hydrogen orthophosphate, 1 mM EDTA, 0.1% CHAPS, 4 mM DTT, pH 5.8 for legumain, 50 mM dihyd...More data for this Ligand-Target Pair
TargetCaspase-3(Homo sapiens (Human))
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
Affinity DataIC50: 5nMpH: 7.0 T: 2°CAssay Description:The substrate peptides terminating in AMC are processed by caspases with or without inhibitors, and the accumulation of AMC was assessed with a Cytof...More data for this Ligand-Target Pair
TargetCaspase-3(Homo sapiens (Human))
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
Affinity DataIC50: 1.80nMpH: 7.0 T: 2°CAssay Description:The substrate peptides terminating in AMC are processed by caspases with or without inhibitors, and the accumulation of AMC was assessed with a Cytof...More data for this Ligand-Target Pair
TargetCaspase-3(Homo sapiens (Human))
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
Affinity DataIC50: 27nMpH: 7.0 T: 2°CAssay Description:The substrate peptides terminating in AMC are processed by caspases with or without inhibitors, and the accumulation of AMC was assessed with a Cytof...More data for this Ligand-Target Pair
TargetCaspase-3(Homo sapiens (Human))
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
Affinity DataIC50: 18nMpH: 7.0 T: 2°CAssay Description:The substrate peptides terminating in AMC are processed by caspases with or without inhibitors, and the accumulation of AMC was assessed with a Cytof...More data for this Ligand-Target Pair
TargetCaspase-3(Homo sapiens (Human))
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
Affinity DataIC50: 176nMpH: 7.0 T: 2°CAssay Description:The substrate peptides terminating in AMC are processed by caspases with or without inhibitors, and the accumulation of AMC was assessed with a Cytof...More data for this Ligand-Target Pair
TargetCaspase-3(Homo sapiens (Human))
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
Affinity DataIC50: 274nMpH: 7.0 T: 2°CAssay Description:The substrate peptides terminating in AMC are processed by caspases with or without inhibitors, and the accumulation of AMC was assessed with a Cytof...More data for this Ligand-Target Pair
TargetCaspase-3(Homo sapiens (Human))
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
Affinity DataIC50: 181nMpH: 7.0 T: 2°CAssay Description:The substrate peptides terminating in AMC are processed by caspases with or without inhibitors, and the accumulation of AMC was assessed with a Cytof...More data for this Ligand-Target Pair
TargetCaspase-3(Homo sapiens (Human))
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
Affinity DataIC50: 9.45E+3nMpH: 7.0 T: 2°CAssay Description:The substrate peptides terminating in AMC are processed by caspases with or without inhibitors, and the accumulation of AMC was assessed with a Cytof...More data for this Ligand-Target Pair
TargetCaspase-3(Homo sapiens (Human))
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
Affinity DataIC50: 323nMpH: 7.0 T: 2°CAssay Description:The substrate peptides terminating in AMC are processed by caspases with or without inhibitors, and the accumulation of AMC was assessed with a Cytof...More data for this Ligand-Target Pair
TargetCaspase-3(Homo sapiens (Human))
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
Affinity DataIC50: 80nMpH: 7.0 T: 2°CAssay Description:The substrate peptides terminating in AMC are processed by caspases with or without inhibitors, and the accumulation of AMC was assessed with a Cytof...More data for this Ligand-Target Pair
TargetCaspase-3(Homo sapiens (Human))
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
Affinity DataIC50: 341nMpH: 7.0 T: 2°CAssay Description:The substrate peptides terminating in AMC are processed by caspases with or without inhibitors, and the accumulation of AMC was assessed with a Cytof...More data for this Ligand-Target Pair
TargetCaspase-3(Homo sapiens (Human))
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
Affinity DataIC50: 17nMpH: 7.0 T: 2°CAssay Description:The substrate peptides terminating in AMC are processed by caspases with or without inhibitors, and the accumulation of AMC was assessed with a Cytof...More data for this Ligand-Target Pair
TargetCaspase-3(Homo sapiens (Human))
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
Affinity DataIC50: 746nMpH: 7.0 T: 2°CAssay Description:The substrate peptides terminating in AMC are processed by caspases with or without inhibitors, and the accumulation of AMC was assessed with a Cytof...More data for this Ligand-Target Pair
TargetCaspase-3(Homo sapiens (Human))
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
Affinity DataIC50: 41nMpH: 7.0 T: 2°CAssay Description:The substrate peptides terminating in AMC are processed by caspases with or without inhibitors, and the accumulation of AMC was assessed with a Cytof...More data for this Ligand-Target Pair
TargetCaspase-3(Homo sapiens (Human))
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
Affinity DataIC50: 100nMpH: 7.0 T: 2°CAssay Description:The substrate peptides terminating in AMC are processed by caspases with or without inhibitors, and the accumulation of AMC was assessed with a Cytof...More data for this Ligand-Target Pair
TargetCaspase-3(Homo sapiens (Human))
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
Affinity DataIC50: 330nMpH: 7.0 T: 2°CAssay Description:The substrate peptides terminating in AMC are processed by caspases with or without inhibitors, and the accumulation of AMC was assessed with a Cytof...More data for this Ligand-Target Pair
TargetCaspase-3(Homo sapiens (Human))
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
Affinity DataIC50: 118nMpH: 7.0 T: 2°CAssay Description:The substrate peptides terminating in AMC are processed by caspases with or without inhibitors, and the accumulation of AMC was assessed with a Cytof...More data for this Ligand-Target Pair
TargetCaspase-3(Homo sapiens (Human))
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
Affinity DataIC50: 425nMpH: 7.0 T: 2°CAssay Description:The substrate peptides terminating in AMC are processed by caspases with or without inhibitors, and the accumulation of AMC was assessed with a Cytof...More data for this Ligand-Target Pair
TargetCaspase-3(Homo sapiens (Human))
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
Affinity DataIC50: 27nMpH: 7.0 T: 2°CAssay Description:The substrate peptides terminating in AMC are processed by caspases with or without inhibitors, and the accumulation of AMC was assessed with a Cytof...More data for this Ligand-Target Pair
TargetCaspase-3(Homo sapiens (Human))
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
Affinity DataIC50: 2.30E+4nMpH: 7.0 T: 2°CAssay Description:The substrate peptides terminating in AMC are processed by caspases with or without inhibitors, and the accumulation of AMC was assessed with a Cytof...More data for this Ligand-Target Pair
TargetCaspase-3(Homo sapiens (Human))
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
Affinity DataIC50: 5.50E+4nMpH: 7.0 T: 2°CAssay Description:The substrate peptides terminating in AMC are processed by caspases with or without inhibitors, and the accumulation of AMC was assessed with a Cytof...More data for this Ligand-Target Pair
TargetCaspase-3(Homo sapiens (Human))
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
Affinity DataIC50: 1.00E+4nMpH: 7.0 T: 2°CAssay Description:The substrate peptides terminating in AMC are processed by caspases with or without inhibitors, and the accumulation of AMC was assessed with a Cytof...More data for this Ligand-Target Pair
TargetCaspase-3(Homo sapiens (Human))
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
Affinity DataIC50: >2.00E+5nMpH: 7.0 T: 2°CAssay Description:The substrate peptides terminating in AMC are processed by caspases with or without inhibitors, and the accumulation of AMC was assessed with a Cytof...More data for this Ligand-Target Pair
TargetCaspase-3(Homo sapiens (Human))
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
Affinity DataIC50: 6.00E+3nMpH: 7.0 T: 2°CAssay Description:The substrate peptides terminating in AMC are processed by caspases with or without inhibitors, and the accumulation of AMC was assessed with a Cytof...More data for this Ligand-Target Pair
TargetCaspase-3(Homo sapiens (Human))
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
Affinity DataIC50: 6.37E+4nMpH: 7.0 T: 2°CAssay Description:The substrate peptides terminating in AMC are processed by caspases with or without inhibitors, and the accumulation of AMC was assessed with a Cytof...More data for this Ligand-Target Pair
TargetCaspase-3(Homo sapiens (Human))
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
Affinity DataIC50: 1.37E+4nMpH: 7.0 T: 2°CAssay Description:The substrate peptides terminating in AMC are processed by caspases with or without inhibitors, and the accumulation of AMC was assessed with a Cytof...More data for this Ligand-Target Pair
TargetCaspase-3(Homo sapiens (Human))
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
Affinity DataIC50: 9.69E+4nMpH: 7.0 T: 2°CAssay Description:The substrate peptides terminating in AMC are processed by caspases with or without inhibitors, and the accumulation of AMC was assessed with a Cytof...More data for this Ligand-Target Pair
TargetCaspase-3(Homo sapiens (Human))
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
Affinity DataIC50: 1.17E+4nMpH: 7.0 T: 2°CAssay Description:The substrate peptides terminating in AMC are processed by caspases with or without inhibitors, and the accumulation of AMC was assessed with a Cytof...More data for this Ligand-Target Pair
TargetCaspase-3(Homo sapiens (Human))
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
Affinity DataIC50: 1.10E+3nMpH: 7.0 T: 2°CAssay Description:The substrate peptides terminating in AMC are processed by caspases with or without inhibitors, and the accumulation of AMC was assessed with a Cytof...More data for this Ligand-Target Pair
TargetCaspase-3(Homo sapiens (Human))
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
Affinity DataIC50: 1.20E+3nMpH: 7.0 T: 2°CAssay Description:The substrate peptides terminating in AMC are processed by caspases with or without inhibitors, and the accumulation of AMC was assessed with a Cytof...More data for this Ligand-Target Pair
TargetCaspase-3(Homo sapiens (Human))
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
Affinity DataIC50: 620nMpH: 7.0 T: 2°CAssay Description:The substrate peptides terminating in AMC are processed by caspases with or without inhibitors, and the accumulation of AMC was assessed with a Cytof...More data for this Ligand-Target Pair
TargetCaspase-3(Homo sapiens (Human))
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
Affinity DataIC50: 410nMpH: 7.0 T: 2°CAssay Description:The substrate peptides terminating in AMC are processed by caspases with or without inhibitors, and the accumulation of AMC was assessed with a Cytof...More data for this Ligand-Target Pair
TargetCaspase-3(Homo sapiens (Human))
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
Affinity DataIC50: 43.9nMpH: 7.0 T: 2°CAssay Description:The substrate peptides terminating in AMC are processed by caspases with or without inhibitors, and the accumulation of AMC was assessed with a Cytof...More data for this Ligand-Target Pair
TargetCaspase-3(Homo sapiens (Human))
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
Affinity DataIC50: 0.771nMpH: 7.0 T: 2°CAssay Description:The substrate peptides terminating in AMC are processed by caspases with or without inhibitors, and the accumulation of AMC was assessed with a Cytof...More data for this Ligand-Target Pair
TargetCaspase-3(Homo sapiens (Human))
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
Affinity DataIC50: 7.95nMpH: 7.0 T: 2°CAssay Description:The substrate peptides terminating in AMC are processed by caspases with or without inhibitors, and the accumulation of AMC was assessed with a Cytof...More data for this Ligand-Target Pair
TargetCaspase-3(Homo sapiens (Human))
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
Affinity DataIC50: 3nMpH: 7.0 T: 2°CAssay Description:The substrate peptides terminating in AMC are processed by caspases with or without inhibitors, and the accumulation of AMC was assessed with a Cytof...More data for this Ligand-Target Pair
TargetCaspase-3(Homo sapiens (Human))
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
Affinity DataIC50: 17.7nMpH: 7.0 T: 2°CAssay Description:The substrate peptides terminating in AMC are processed by caspases with or without inhibitors, and the accumulation of AMC was assessed with a Cytof...More data for this Ligand-Target Pair
TargetCaspase-3(Homo sapiens (Human))
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
Affinity DataIC50: 9.17nMpH: 7.0 T: 2°CAssay Description:The substrate peptides terminating in AMC are processed by caspases with or without inhibitors, and the accumulation of AMC was assessed with a Cytof...More data for this Ligand-Target Pair
TargetCaspase-3(Homo sapiens (Human))
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
Affinity DataIC50: 6.12E+3nMpH: 7.0 T: 2°CAssay Description:The substrate peptides terminating in AMC are processed by caspases with or without inhibitors, and the accumulation of AMC was assessed with a Cytof...More data for this Ligand-Target Pair
TargetCaspase-3(Homo sapiens (Human))
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
Affinity DataIC50: 1.74E+3nMpH: 7.0 T: 2°CAssay Description:The substrate peptides terminating in AMC are processed by caspases with or without inhibitors, and the accumulation of AMC was assessed with a Cytof...More data for this Ligand-Target Pair
TargetCaspase-3(Homo sapiens (Human))
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
Affinity DataIC50: 48nMpH: 7.0 T: 2°CAssay Description:The substrate peptides terminating in AMC are processed by caspases with or without inhibitors, and the accumulation of AMC was assessed with a Cytof...More data for this Ligand-Target Pair
TargetCaspase-3(Homo sapiens (Human))
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
Affinity DataIC50: 140nMpH: 7.0 T: 2°CAssay Description:The substrate peptides terminating in AMC are processed by caspases with or without inhibitors, and the accumulation of AMC was assessed with a Cytof...More data for this Ligand-Target Pair
TargetCaspase-3(Homo sapiens (Human))
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
Affinity DataIC50: 83nMpH: 7.0 T: 2°CAssay Description:The substrate peptides terminating in AMC are processed by caspases with or without inhibitors, and the accumulation of AMC was assessed with a Cytof...More data for this Ligand-Target Pair
TargetCaspase-3(Homo sapiens (Human))
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
Affinity DataIC50: 130nMpH: 7.0 T: 2°CAssay Description:The substrate peptides terminating in AMC are processed by caspases with or without inhibitors, and the accumulation of AMC was assessed with a Cytof...More data for this Ligand-Target Pair
TargetCaspase-3(Homo sapiens (Human))
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
Affinity DataIC50: 73nMpH: 7.0 T: 2°CAssay Description:The substrate peptides terminating in AMC are processed by caspases with or without inhibitors, and the accumulation of AMC was assessed with a Cytof...More data for this Ligand-Target Pair
TargetCaspase-3(Homo sapiens (Human))
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
Affinity DataIC50: 63nMpH: 7.0 T: 2°CAssay Description:The substrate peptides terminating in AMC are processed by caspases with or without inhibitors, and the accumulation of AMC was assessed with a Cytof...More data for this Ligand-Target Pair
TargetCaspase-3(Homo sapiens (Human))
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
The Board Of Trustees Of The Leland Stanford Junior University
US Patent
Affinity DataIC50: 310nMpH: 7.0 T: 2°CAssay Description:The substrate peptides terminating in AMC are processed by caspases with or without inhibitors, and the accumulation of AMC was assessed with a Cytof...More data for this Ligand-Target Pair